University of California San Francisco

Chris E. Freise, MD, FACS

Chris E. Freise
Chris
Freise
MD, FACS

Professor and Chief, Division of Transplant Surgery

UCSF Diversity, Equity, and Inclusion Champion badge

Address

35 Medical Center Way, #902D
San Francisco, CA 94143
United States

    Biography

    Chris E. Freise, M.D. received his medical degree from the University of Minnesota where he also did his internship and residency in General Surgery. He later completed a  transplantation fellowship at UCSF.   

    He is a member of numerous professional organizations including The Transplantation Society, the International Pancreas and Islet Transplant Association, the Transplant Infectious Disease Society, the American Hepato-Pancreato-Billiary Association and the Society of University Surgeons. In addition, he recently served as the Medical Director for California Transplant Donor Network. He is also the Associate Counselor for UNOS Region 5, and a member of the UNOS Membership and Professional Standards Committee.

    Dr. Freise has authored more than eighty (80) in peer-reviewed publications and five (5) book chapters. He is an accomplished researcher and clinical educator. Dr. Freise is also a frequent invited lecturer to national and international and conferences in the field.         

    Education

    Institution Degree Dept or School End Date
    University of California Diversity, Equity, and Inclusion Champion Training 2019
    University of California, San Francisco Transplant Fellowship School of Medicine 1995
    University of California, San Francisco Post-Doc Fellow/Scholar School of Medicine 1991
    University of Minnesota M.D. School of Medicine 1986

    Board Certifications

    • American Board of Surgery, 1995

    Clinical Expertise

    Bile Duct Injuries
    Bile Duct Strictures
    Cholangiocarcinoma (Bile Duct Cancer)
    Choledochal Cyst Disease
    Dialysis Access
    Expanded Criteria Donor Kidney Transplantation
    Fulminant Hepatic Failure
    Hepatitis B
    Hepatitis C
    Hepatocellular Carcinoma (Liver Cancer)
    Intestinal Transplantation and Rehabilitation
    Kidney and LIver Transplantation in HIV Patients
    Kidney Auto-transplantation
    Kidney Transplantation
    Laparoscopic Donor Nephrectomy
    Laparoscopic Kidney and Liver Surgery
    Liver Transplantation
    Living Donor Kidney Transplantation
    Living Donor Liver Transplantation
    Pancreas Transplantation
    Pediatric Kidney Transplantation
    Pediatric Liver Transplantation
    Polycystic Kidney Disease
    Polycystic Liver Disease
    Portal Hypertension
    Surgical Shunts

    Grants and Funding

    • Living Donor Liver Transplant :Short & Long-Term Impact on Donors and Recipients | NIH | 2002-09-01 - 2015-08-31 | Role: Principal Investigator

    Research Narrative

    Dr. Friese's basic science research focuses on the delivery of immunosuppressive agents to organ allografts, ischemia reperfusion injury, and methods to improve organ function in deceased donors. His clinical research includes  a multicenter trial investigating donor and recipient outcomes following living donor liver transplantation.

    Research Interests

    Delivery of Immunosuppressive Agents to Organ Allografts

    Ischemia Reperfusion Injury

    Improvement Organ Function in Deceased Donors

    Publications

    MOST RECENT PUBLICATIONS FROM A TOTAL OF 10
    1. Portal Vein Thrombectomy in Liver Transplantation for Patients With Calcified Portal Vein Thrombosis: An Extensive Case Series.
      Altshuler PJ, Roll GR, Chu SN, Zheng AC, Record HL, Hasan H, Freise CE, Yamaguchi S, Roberts JP, Syed SM| | PubMed
    2. Outcomes from Referral to Transplant for Patients with MASLD: A California Liver Network Study.
      Lim TY, Steggerda JA, Trivedi H, Luu M, Vipani A, Adjei MA, Singh J, Zhou K, Kwong A, Tincopa M, Vodkin I, Ajmera V, Mehta N, Freise CE, Yilma M, Hirose R, Kuo A, Wisel SA| | PubMed
    3. Steroid Withdrawal Versus Maintenance in Simultaneous Pancreas-Kidney Transplantation: Long-Term Outcomes in a Single-Center Retrospective Cohort.
      Meier RPH, Abbasi AB, Gamino G, Kelly YM, Tavakol M, Conti G, Sarwal M, Stock PG, Freise CE| | PubMed
    4. Pre-Donation Cardiac Arrest and Liver Transplantation Outcomes: Implications for Ischemic Preconditioning.
      Amarnath DR, Tingle SJ, Kourounis G, Freise C, Roll GR, Yamaguchi S, Rickert C, Wilson CH| | PubMed
    5. Renal Autotransplantation: Association Between Preoperative Disease Duration and Surgical Outcomes.
      Li KD, Pearce RJ, Sui W, Yang H, Freise C, Roll GR, Chi T, Stoller ML| | PubMed
    6. Case presentation and review of renal autotransplantation for nutcracker syndrome.
      Li KD, Bowman MS, Yang H, Sui W, Freise C, Stoller M| | PubMed
    7. Ureteral avulsion after ureteroscopy treated with renal auto-transplantation.
      Sanampudi R, Velasquez MC, Freise CE, Stoller ML| | PubMed
    8. Abdominal lymphocele following multi-level anterior lumbar interbody fusion (ALIF) managed with a laparoscopic peritoneal window: case report and review of the literature.
      Collins AP, Freise CE, Hiramoto J, Clark AJ, Theologis AA| | PubMed
    9. Peritoneal Dialysis Catheter Complications after Insertion by Surgeons, Radiologists, or Nephrologists.
      Ku E, Copeland T, McCulloch CE, Freise C, Legaspi S, Weinhandl E, Woo K, Johansen KL| | PubMed
    10. DCD liver transplant in patients with a MELD over 35.
      Meier RPH, Nunez M, Syed SM, Feng S, Tavakol M, Freise CE, Roberts JP, Ascher NL, Hirose R, Roll GR| | PubMed